Quantitative affinity-based chemical proteomics of TrkA inhibitors†
Abstract
Quantitative chemical proteomics enabled affinity-isolation and enrichment of the
Maintenance work is planned from 09:00 BST to 12:00 BST on Saturday 28th September 2024.
During this time the performance of our website may be affected - searches may run slowly, some pages may be temporarily unavailable, and you may be unable to access content. If this happens, please try refreshing your web browser or try waiting two to three minutes before trying again.
We apologise for any inconvenience this might cause and thank you for your patience.
* Corresponding authors
a Chemical Biology Group, World Wide Medicinal Chemistry, Sandwich Laboratories, Pfizer, Ramsgate Road, Sandwich, Kent, UK
b Structural Biology and Biophysics, World Wide Medicinal Chemistry, Sandwich Laboratories, Pfizer, Ramsgate Road, Sandwich, Kent, UK
c
Chemical Biology and Orphan & Genetics Diseases, World Wide Medicinal Chemistry, Pfizer, 200 Cambridge Park Drive, Cambridge, MA, USA
E-mail:
lyn.jones@pfizer.com
Tel: +1 617 665 5631
Quantitative chemical proteomics enabled affinity-isolation and enrichment of the
V. E. Albrow, C. Fernandes, D. M. Beal, M. D. Selby, M. Fernandez-Ocaña, K. C. Rumpel and L. H. Jones, Med. Chem. Commun., 2012, 3, 322 DOI: 10.1039/C2MD00271J
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content